Anti-factor XA levels in critically ill trauma patients treated for venous thromboembolism with enoxaparin.

被引：0
|
作者：
Sing, R
Barrett, MC
Huynh, T
Miles, W
Jacobs, D
Thomason, M
Rutherford, EJ
机构：
[1] Carolinas Med Ctr, Charlotte, NC 28203 USA
[2] Wake Forest Univ, Raleigh, NC USA
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00601
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [1] Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
    Dibiasi, Christoph
    Gratz, Johannes
    Wiegele, Marion
    Baierl, Andreas
    Schaden, Eva
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [2] Anti-Factor Xa Activity of Prophylactic Enoxaparin Regimens in Critically Ill Patients
    Helviz, Yigal
    Dzigivker, Ilia
    Raveh-Brawer, David
    Hersch, Moshe
    Zevin, Shoshana
    Einav, Sharon
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (02): : 108 - 113
  • [3] Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma
    Karcutskie, Charles A.
    Dharmaraja, Arjuna
    Patel, Jaimin
    Eidelson, Sarah A.
    Padiadpu, Anish B.
    Martin, Arch G.
    Lama, Gabriel
    Lineen, Edward B.
    Namias, Nicholas
    Schulman, Carl I.
    Proctor, Kenneth G.
    [J]. JAMA SURGERY, 2018, 153 (02) : 144 - 149
  • [4] Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients
    Gates, Rebecca S.
    Lollar, Daniel, I
    Collier, Bryan R.
    Smith, Jacob
    Faulks, Emily R.
    Gillen, Jacob R.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2022, 92 (01): : 93 - 97
  • [5] ANTI-FACTOR Xa MEASUREMENTS IN CRITICALLY-ILL SURGICAL PATIENTS TO EXAMINE ENOXAPARIN METABOLISM AND OPTIMIZE ENOXAPARIN DOSE
    Wall, V
    Fleming, K.
    Pannucci, C.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 163 - 163
  • [6] Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
    Al Otaib, Nouf
    Bootah, Zohour
    Al Ammari, Maha A.
    Aldebasi, Tariq M.
    Alkatheri, Abdulmalik M.
    Al Harbi, Shmeylan A.
    AbuRuz, Salah M.
    AlBekairy, Abdulkareem M.
    [J]. ANNALS OF THORACIC MEDICINE, 2017, 12 (03) : 199 - 203
  • [7] ANTI-FACTOR XA LEVELS IN PICU PATIENTS ON ENOXAPARIN FOR VENOTHROMBOEMBOLISM PROPHYLAXIS
    Marshall, Amanda
    Malone, Matthew
    Yee, Addison
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [8] Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis
    Pannucci, Christopher J.
    Prazak, Ann Marie
    Scheefer, Melody
    [J]. AMERICAN JOURNAL OF SURGERY, 2017, 213 (06): : 1143 - 1152
  • [9] Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
    Hakeam, Hakeam A.
    Al Duhailib, Zainab
    Alsemari, Muhannad
    Alwaibah, Reem M.
    Al Shannan, Madhawi F.
    Shalhoub, Munirah
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [10] Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
    Tharanon, Vichapat
    Kawamatawong, Theerasuk
    [J]. SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
12345